Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Edem Kpormegbey
Observed names:
Daniel E Kpormegbey,
Daniel E. Kpormegbey,
Kpormegbey, Daniel E,
Kpormegbey, Daniel Edem
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Indiana University Bloomington
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
University of Connecticut,
Indiana University Bloomington,
Indiana University
ORCID:
0009-0001-1655-8581
Observed ORCID:
0009-0001-1655-8581
OpenAlex ID:
A5093457159
A Primer of Data Cleaning in Quantitative Research: Handling Missing Values and Outliers
2025
·
Amir Masoud Sharifnia
, Daniel Edem Kpormegbey
, et al.
·
Journal of Advanced Nursing
·
91
Pair‐Feeding Study Designs Can Create Biases and Inflate Type I Error Rates: A Simulation Study
2025
·
Wasiuddin Najam
, Daniel E. Kpormegbey
, et al.
·
Obesity
·
3
PDF
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer
2026
·
Nooshin Mirkheshti
, Daniel Edem Kpormegbey
, et al.
·
Clinical Cancer Research
·
2
PDF
Ambiguity in Statistical Analysis Methods and Nonconformity With Prespecified Commitment to Data Sharing in a Cluster Randomized Controlled Trial
2024
·
Yasaman Jamshidi-Naeini
, Lilian Golzarri-Arroyo
, et al.
·
Journal of Medical Internet Research
·
2
PDF
Examining Demand and Substitutability of Usual Brand Little Cigars/Cigarillos and Cigarettes in Young Adults Who Dual Use
2024
·
Erin L Mead-Morse
, Rachel N Cassidy
, et al.
·
Nicotine & Tobacco Research
·
2
PDF
Data from FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer
2026
·
Nooshin Mirkheshti
, Daniel Edem Kpormegbey
, et al.
Supplementary Table S1 from FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer
2026
·
Nooshin Mirkheshti
, Daniel Edem Kpormegbey
, et al.
Reanalyzing Castner et al. confirms most conclusions, reveals additional findings, and detects some statistical errors
2026
·
Olivia C. Robertson
, Erik Parker
, et al.
·
Journal of Robustness Reports
PDF
217 The impact of preoperative glucagon-like peptide-1 receptor agonists (GLP1) utilization on bariatric surgery outcomes
2025
·
Tarik Yuce
, Qais AbuHasan
, et al.
·
Journal of Clinical and Translational Science
PDF
Show more works
View as search
Works count:
12
Citation count:
102
H-index:
2
I10-index:
1
Year
Topic
Type